DNA甲基化:在空气污染暴露和喘控制之间是一个潜在的调解者
My-Nhi Nguyen1, Katelyn Queen2, Frank D Gilliland2
1Department of Population and Public Health Sciences, University of Southern California, Los Angeles, CA, USA. ngocmynh@usc.edu.
Clinical epigenetics
|October 22, 2025
概括
暴露于空气污染,特别是短期的PM10,与较差的喘控制有关. 血液细胞中的DNA甲基化变化可能会调解这种关系,从而提供有关喘病理生理学的见解.
科学领域:
- 环境表观遗传学环境表观遗传学
- 呼吸系统医学 呼吸系统医学
- 分子流行病学分子流行病学
背景情况:
- 空气污染是已知的喘恶化因素,其中涉及DNA甲基化 (DNAm) 的机制被假设.
- 了解空气污染等环境暴露如何通过表观遗传修饰影响喘控制至关重要.
研究的目的:
- 调查空气污染暴露与外周血液和T细胞中的DNAm之间的关联.
- 探索DNAm在空气污染和喘控制之间的关系中的潜在调解作用.
主要方法:
- 在651名暴露于各种空气污染物 (NO2,PM2.5,PM10,O3,EC,NOx) 的喘患者上进行了表观基因组广泛关联研究 (EWAS).
- 使用喘控制测试 (ACT) 成绩评估喘控制.
- 在全血和CD4+天真T细胞中使用Infinium HumanMethylation450 BeadChip阵列量化DNAm.
- 使用因果推理测试 (CIT) 来分析DNAm的调解.
主要成果:
- 短期的PM10暴露与降低喘控制相关.
- 鉴定了与PM10,EC,NOx (全血) 和PM10,NO2,PM2.5 (CD4+细胞) 相关的显著DNAm变化.
- 特定的CpG地点 (例如,cg04605532,cg10022248) 与空气污染暴露和喘控制有关.
- CIT分析表明,两个CpG位点 (cg02324789,cg10758278) 可能会调解PM10对喘控制的影响.
结论:
- 空气污染引起的DNA甲基化变化可能会影响特定位置的喘控制.
- 这些表观遗传变化为了解与空气污染相关的喘病理学提供了潜在的目标.
- 需要进一步的研究来证实因果关系,并阐明空气污染,DNA甲基化和喘之间的复杂相互作用.
更多相关视频
11:19Correlating Gene-specific DNA Methylation Changes with Expression and Transcriptional Activity of Astrocytic KCNJ10 Kir4.1
Published on: September 26, 2015
8.4K
13:11Optimized Analysis of DNA Methylation and Gene Expression from Small, Anatomically-defined Areas of the Brain
Published on: July 12, 2012
19.3K
相关概念视频
01:20Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
01:29Asthma-I: Introduction
3.4K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.4K
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
01:26Asthma-II: Pathophysiology and Classification
4.1K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.1K
01:30Asthma-IV: Diagnostic and Management
3.1K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.1K
01:24Antiasthma Drugs: Methylxanthines
1.6K
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
1.6K